Trial NCT02514447

View at ClinicalTrials.gov 
Org. Study IDs: G1T28-03
Secondary IDs: 2016-004611-13

Last trial update was posted on 2022-06-09

MeSH Interventions

Topotecan

MeSH Conditions

Lung Neoplasms Small Cell Lung Carcinoma

Other Conditions

Small Cell Lung Cancer

Stopping Reasons

Primary Analysis and survival follow up completed per protocol. Not stopped due to safety concerns.

Limitations And Caveats

Limitation of the trial is small numbers of subjects, since it is a Phase 2 clinical trial. Small sample size may have reduced the ability to observe statistically significant treatment effects on secondary myelopreservation measures (i.e. occurrence of FN AEs, infections and antibiotics usage).

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID